Renol Polychem

Is Renol Polychem overvalued or undervalued?

As of December 4, 2025, Renol Polychem is considered very attractive and undervalued, with a PE ratio of 23.83, an EV to EBIT of 16.60, and a ROCE of 19.71%, outperforming peers like Sudarshan Chem and Kiri Industries, and showing a 1-month return of 14.81% compared to the Sensex's 1.70%.

As of 4 December 2025, the valuation grade for Renol Polychem has moved from attractive to very attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued. Key ratios include a PE ratio of 23.83, an EV to EBIT of 16.60, and a ROCE of 19.71%. <BR><BR>In comparison to peers, Renol Polychem's PE ratio is significantly lower than Sudarshan Chem's 130.12 and Kiri Industries' 30.05, both of which are in less favorable valuation positions. Additionally, Renol's EV to EBITDA ratio of 16.28 is more attractive than that of Indokem, which stands at 239.79. The recent stock performance shows a 1-month return of 14.81%, outperforming the Sensex's 1.70% return, reinforcing the notion that Renol Polychem is positioned well in the market.

Which are the latest news on Renol Polychem?

Why is Renol Polychem Ltd falling/rising?

As of 13-Feb, Renol Polychem Ltd's stock price is at 146.90, showing a slight increase and strong performance over the past week, outperforming the Sensex. Despite a drop in delivery volume, the stock remains above key moving averages, indicating a positive trend and adequate liquidity for trading.

As of 13-Feb, Renol Polychem Ltd's stock price is rising, currently at 146.90, reflecting a slight increase of 0.1 (0.07%). The stock has shown strong performance over the past week, with a return of +3.41%, significantly outperforming the Sensex, which has declined by -0.87% during the same period. Additionally, the stock has positive returns over the past month (+1.45%) and year-to-date (+4.18%), while the Sensex has experienced losses in these timeframes.<BR><BR>Despite a decrease in investor participation, as indicated by a -31.03% drop in delivery volume compared to the 5-day average, the stock remains above its 5-day, 50-day, 100-day, and 200-day moving averages, suggesting a generally positive trend. The stock's liquidity is also adequate for trading, which supports its price stability. Overall, the combination of recent performance metrics and relative strength against the benchmark indicates that Renol Polychem Ltd is experiencing a rise in its stock price.